⁶⁸Ga-DOTANOC and ¹⁸F-FDG PET/CT in metastatic medullary thyroid carcinoma: novel correlations with tumoral biomarkers

Metastatic disease is common in medullary thyroid carcinoma (MTC) and it is usually detected by raising calcitonin and carcinoembryonic antigen (CEA) levels. Nuclear medicine imaging has an important role in lesion identification/characterisation. We aim to compare ⁶⁸Ga-DOTANOC PET/CT and ¹⁸F-FDG PET/CT performance and to explore the correlations between tumoral markers and functional imaging.

This a retrospective cross-sectional study including 13 patients with MTC and high calcitonin/CEA levels that underwent both ⁶⁸Ga-DOTANOC PET/CT and ¹⁸F-FDG PET/CT.

⁶⁸Ga-DOTANOC PET/CT identified MTC metastases in 2twopatients that were ¹⁸F-FDG-negative (sensitivity of 69.2% vs. 53.9%, respectively). ⁶⁸Ga-DOTANOC PET/CT also detected a higher number of lesions than ¹⁸F-FDG PET/CT in seven patients, with only one patient showing the opposite pattern. Both differences lacked statistical significance (p = 0.50 and p = 0.86, respectively) but ⁶⁸Ga-DOTANOC PET/CT better performance allowed changes in patients’ management. ⁶⁸Ga-positive/¹⁸F-FDG-negative patients were the ones with the lowest calcitonin doubling time and presented a CEA doubling time >24 months, while the patient with more ¹⁸F-FDG-positive lesions was the one with the highest CEA/calcitonin ratio. The number of lesions found in ⁶⁸Ga-DOTANOC PET/CT were correlated with calcitonin levels (r = 0.73; p < 0.01) but not with CEA ones (r = 0.42; p = 0.15). The number of ¹⁸F-FDG hypermetabolic focus were correlated with CEA levels (r = 0.60; p < 0.05) but not with calcitonin (r = 0.48; p = 0.09).

This is the first study to describe a positive correlation between ⁶⁸Ga-positive lesions and calcitonin levels and between ¹⁸F-FDG-positivity and CEA levels. Tumoral markers pattern in metastatic MTC could help clinicians to decide which exam to perform first.